660 related articles for article (PubMed ID: 27514756)
1. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
Zhang K; Guo Y; Ge Z; Zhang Z; Da Y; Li W; Zhang Z; Xue Z; Li Y; Ren Y; Jia L; Chan KH; Yang F; Yan J; Yao Z; Xu A; Zhang R
Mol Neurobiol; 2017 Sep; 54(7):4908-4920. PubMed ID: 27514756
[TBL] [Abstract][Full Text] [Related]
2. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
[TBL] [Abstract][Full Text] [Related]
3. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
4. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
Lee J; Choi J; Lee W; Ko K; Kim S
Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
6. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
[TBL] [Abstract][Full Text] [Related]
7. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
8. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
[TBL] [Abstract][Full Text] [Related]
9. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
[TBL] [Abstract][Full Text] [Related]
10. Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis.
Zhang Z; Zhang K; Zhang M; Zhang X; Zhang R
Front Immunol; 2022; 13():856694. PubMed ID: 35514960
[TBL] [Abstract][Full Text] [Related]
11. RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Park TY; Park SD; Cho JY; Moon JS; Kim NY; Park K; Seong RH; Lee SW; Morio T; Bothwell AL; Lee SK
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18673-8. PubMed ID: 25527718
[TBL] [Abstract][Full Text] [Related]
12. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
[TBL] [Abstract][Full Text] [Related]
13. miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORγt and STAT3.
Zhu E; Wang X; Zheng B; Wang Q; Hao J; Chen S; Zhao Q; Zhao L; Wu Z; Yin Z
J Immunol; 2014 Jun; 192(12):5599-609. PubMed ID: 24842756
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of TAK-828F, a novel orally available RORγt inverse agonist, on murine chronic experimental autoimmune encephalomyelitis model.
Nakamura Y; Igaki K; Uga K; Shibata A; Yamauchi H; Yamasaki M; Tsuchimori N
J Neuroimmunol; 2019 Oct; 335():577016. PubMed ID: 31374381
[TBL] [Abstract][Full Text] [Related]
15. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Kong W; Li H; Tuma RF; Ganea D
Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422
[TBL] [Abstract][Full Text] [Related]
16. Th17 cell promotes apoptosis of IL-23R
Sonar SA; Meitei HT; Karmakar S; Mishra A; Inamdar S; Lenka N; Lal G
Clin Immunol; 2024 Feb; 259():109898. PubMed ID: 38185267
[TBL] [Abstract][Full Text] [Related]
17. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.
Kang Y; Timilshina M; Nam TG; Jeong BS; Chang JH
Biol Res; 2017 Feb; 50(1):8. PubMed ID: 28241881
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
[TBL] [Abstract][Full Text] [Related]
19. Eriodictyol suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis.
Yang T; Li X; Yu J; Deng X; Shen PX; Jiang YB; Zhu L; Wang ZZ; Zhang Y
Food Funct; 2020 Aug; 11(8):6875-6888. PubMed ID: 32686813
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.
Kanakasabai S; Chearwae W; Walline CC; Iams W; Adams SM; Bright JJ
Immunology; 2010 Aug; 130(4):572-88. PubMed ID: 20406305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]